Evidence of accelerated epigenetic aging in trisomy 21 patients [159] and of low levels of cellular senescence in BubR1-overexpressing mice [83] reinforce the impact of mitotic competence in the epigenetics and cellular senescence. The gene discussed is BUB1B; the disease is trisomy 21.